Product Information
ROPINIROLE HCL ER 8 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $1.1188 per EA under NDC 00228366009. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
8 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228366009
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090869On Market Since
8/23/2012
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 8 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 78.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1188 per EA |
|---|---|
| All-time high | $5.9283 (Feb 12, 2014) |
| All-time low | $0.7082 (Nov 23, 2022) |
| 52-week high | $1.5441 |
| 52-week low | $0.7180 |
| Median price | $2.1859 |
| Average price | $2.5685 |
| Largest weekly change | +104.0% (Dec 21, 2022) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 8 MG TABLET, manufactured by Actavis Pharma, Inc., is $1.1188 per EA (NDC 00228366009), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL ER 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 8 MG TABLET has declined 78.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 8 MG TABLET?
Since Nov 28, 2013, the NADAC for ROPINIROLE HCL ER 8 MG TABLET has ranged from a low of $0.7082 (Nov 23, 2022) to a high of $5.9283 (Feb 12, 2014), with a median of $2.1859 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 8 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ROPINIROLE HCL ER 8 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL ER 8 MG TABLET?
ROPINIROLE HCL ER 8 MG TABLET (NDC 00228366009) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification